These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 28737129)

  • 1. Association between polymorphisms in CTR1, CTR2, ATP7A, and ATP7B and platinum resistance in epithelial ovarian cancer.
    Li T; Peng J; Zeng F; Zhang K; Liu J; Li X; Ouyang Q; Wang G; Wang L; Liu Z; Liu Y
    Int J Clin Pharmacol Ther; 2017 Oct; 55(10):774-780. PubMed ID: 28737129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copper transporter 2 regulates the cellular accumulation and cytotoxicity of Cisplatin and Carboplatin.
    Blair BG; Larson CA; Safaei R; Howell SB
    Clin Cancer Res; 2009 Jul; 15(13):4312-21. PubMed ID: 19509135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The contribution of copper efflux transporters ATP7A and ATP7B to chemoresistance and personalized medicine in ovarian cancer.
    Lukanović D; Herzog M; Kobal B; Černe K
    Biomed Pharmacother; 2020 Sep; 129():110401. PubMed ID: 32570116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sec61β controls sensitivity to platinum-containing chemotherapeutic agents through modulation of the copper-transporting ATPase ATP7A.
    Abada PB; Larson CA; Manorek G; Adams P; Howell SB
    Mol Pharmacol; 2012 Sep; 82(3):510-20. PubMed ID: 22710939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the cellular pharmacology of JM118, the major metabolite of satraplatin, by copper influx and efflux transporters.
    Samimi G; Howell SB
    Cancer Chemother Pharmacol; 2006 Jun; 57(6):781-8. PubMed ID: 16170571
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Li YQ; Zhang XY; Chen J; Yin JY; Li XP
    J Cancer Res Ther; 2018; 14(4):881-886. PubMed ID: 29970670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copper efflux transporters ATP7A and ATP7B: Novel biomarkers for platinum drug resistance and targets for therapy.
    Li YQ; Yin JY; Liu ZQ; Li XP
    IUBMB Life; 2018 Mar; 70(3):183-191. PubMed ID: 29394468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of copper transporter expression with platinum resistance in epithelial ovarian cancer.
    Yoshida H; Teramae M; Yamauchi M; Fukuda T; Yasui T; Sumi T; Honda K; Ishiko O
    Anticancer Res; 2013 Apr; 33(4):1409-14. PubMed ID: 23564780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of ATP7A, ATP7B and CTR1 in adult rat dorsal root ganglion tissue.
    Ip V; Liu JJ; Mercer JF; McKeage MJ
    Mol Pain; 2010 Sep; 6():53. PubMed ID: 20836889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells.
    Samimi G; Safaei R; Katano K; Holzer AK; Rochdi M; Tomioka M; Goodman M; Howell SB
    Clin Cancer Res; 2004 Jul; 10(14):4661-9. PubMed ID: 15269138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitization of cancer cells towards Cisplatin and Carboplatin by protein kinase D inhibitors through modulation of ATP7A/B (copper transport ATPases).
    Janardhanan P; Somasundaran AK; Balakrishnan AJ; Pilankatta R
    Cancer Treat Res Commun; 2022; 32():100613. PubMed ID: 35908410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between copper transporters and the prognosis of cancer patients undergoing chemotherapy: a meta-analysis of literatures and datasets.
    Sun S; Cai J; Yang Q; Zhao S; Wang Z
    Oncotarget; 2017 Feb; 8(9):16036-16051. PubMed ID: 27980217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered localisation of the copper efflux transporters ATP7A and ATP7B associated with cisplatin resistance in human ovarian carcinoma cells.
    Kalayda GV; Wagner CH; Buss I; Reedijk J; Jaehde U
    BMC Cancer; 2008 Jun; 8():175. PubMed ID: 18565219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copper efflux transporter (ATP7B) contributes to the acquisition of cisplatin-resistance in human oral squamous cell lines.
    Yoshizawa K; Nozaki S; Kitahara H; Ohara T; Kato K; Kawashiri S; Yamamoto E
    Oncol Rep; 2007 Oct; 18(4):987-91. PubMed ID: 17786364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copper-transporting P-type adenosine triphosphatase (ATP7A) is associated with platinum-resistance in non-small cell lung cancer (NSCLC).
    Li ZH; Qiu MZ; Zeng ZL; Luo HY; Wu WJ; Wang F; Wang ZQ; Zhang DS; Li YH; Xu RH
    J Transl Med; 2012 Feb; 10():21. PubMed ID: 22304828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Targeting of ATP7B in Ovarian Carcinoma.
    Mangala LS; Zuzel V; Schmandt R; Leshane ES; Halder JB; Armaiz-Pena GN; Spannuth WA; Tanaka T; Shahzad MM; Lin YG; Nick AM; Danes CG; Lee JW; Jennings NB; Vivas-Mejia PE; Wolf JK; Coleman RL; Siddik ZH; Lopez-Berestein G; Lutsenko S; Sood AK
    Clin Cancer Res; 2009 Jun; 15(11):3770-80. PubMed ID: 19470734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The roles of copper transporters in cisplatin resistance.
    Kuo MT; Chen HH; Song IS; Savaraj N; Ishikawa T
    Cancer Metastasis Rev; 2007 Mar; 26(1):71-83. PubMed ID: 17318448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of copper and role of the copper transporters ATP7A and CTR1 in intracellular accumulation of cisplatin.
    Matsumoto S; Tanaka T; Kurokawa H; Matsuno K; Hayashida Y; Takahashi T
    Anticancer Res; 2007; 27(4B):2209-16. PubMed ID: 17695505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the cellular pharmacology of cisplatin and its analogs by the copper exporters ATP7A and ATP7B.
    Samimi G; Katano K; Holzer AK; Safaei R; Howell SB
    Mol Pharmacol; 2004 Jul; 66(1):25-32. PubMed ID: 15213293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MircroRNA-139 sensitizes ovarian cancer cell to cisplatin-based chemotherapy through regulation of ATP7A/B.
    Xiao F; Li Y; Wan Y; Xue M
    Cancer Chemother Pharmacol; 2018 May; 81(5):935-947. PubMed ID: 29594361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.